Bollaerts K - Search Results

1

Thyroid cancer incidence around the Belgian nuclear sites: surrogate exposure modelling.

Bollaerts K, Sonck M, Simons K, Fierens S, Poffijn A, Van Bladel L, Geraets D, Gosselin P, Van Oyen H, Francart J, Van Nieuwenhuyse A. Bollaerts K, et al. Cancer Epidemiol. 2015 Feb;39(1):48-54. doi: 10.1016/j.canep.2014.10.011. Epub 2014 Nov 7. Cancer Epidemiol. 2015. PMID: 25475063 Free article.

2

Thyroid cancer incidence in the vicinity of nuclear sites in Belgium, 2000-2008.

Bollaerts K, Fierens S, Van Bladel L, Simons K, Sonck M, Poffijn A, Geraets D, Gosselin P, Van Oyen H, Francart J, Van Nieuwenhuyse A. Bollaerts K, et al. Thyroid. 2014 May;24(5):906-17. doi: 10.1089/thy.2013.0227. Thyroid. 2014. PMID: 24624964

3

Childhood leukaemia near nuclear sites in Belgium, 2002-2008.

Bollaerts K, Simons K, Van Bladel L, De Smedt T, Sonck M, Fierens S, Poffijn A, Geraets D, Gosselin P, Van Oyen H, Francart J, Van Nieuwenhuyse A. Bollaerts K, et al. Eur J Cancer Prev. 2018 Mar;27(2):184-191. doi: 10.1097/CEJ.0000000000000272. Eur J Cancer Prev. 2018. PMID: 27380513 Free PMC article.

4

Thyroid Cancer Incidence around the Belgian Nuclear Sites, 2000-2014.

Demoury C, De Smedt T, De Schutter H, Sonck M, Van Damme N, Bollaerts K, Molenberghs G, Van Bladel L, Van Nieuwenhuyse A. Demoury C, et al. Among authors: bollaerts k. Int J Environ Res Public Health. 2017 Aug 31;14(9):988. doi: 10.3390/ijerph14090988. Int J Environ Res Public Health. 2017. PMID: 28858225 Free PMC article.

5

Contribution of respiratory pathogens to influenza-like illness consultations.

Bollaerts K, Antoine J, Van Casteren V, Ducoffre G, Hens N, Quoilin S. Bollaerts K, et al. Epidemiol Infect. 2013 Oct;141(10):2196-204. doi: 10.1017/S0950268812002506. Epub 2012 Dec 6. Epidemiol Infect. 2013. PMID: 23217849 Free PMC article.

6

Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10.

Bollaerts K, Aerts M, Sasse A. Bollaerts K, et al. Arch Public Health. 2013 May 3;71(1):10. doi: 10.1186/0778-7367-71-10. Arch Public Health. 2013. PMID: 23642251 Free PMC article.

7

Benefit-Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project.

Bollaerts K, De Smedt T, Donegan K, Titievsky L, Bauchau V. Bollaerts K, et al. Drug Saf. 2018 Aug;41(8):775-786. doi: 10.1007/s40264-018-0658-y. Drug Saf. 2018. PMID: 29582392 Free PMC article.

8

Disease misclassification in electronic healthcare database studies: Deriving validity indices-A contribution from the ADVANCE project.

Bollaerts K, Rekkas A, De Smedt T, Dodd C, Andrews N, Gini R. Bollaerts K, et al. PLoS One. 2020 Apr 22;15(4):e0231333. doi: 10.1371/journal.pone.0231333. eCollection 2020. PLoS One. 2020. PMID: 32320422 Free PMC article.

9

Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.

De Smedt T, Merrall E, Macina D, Perez-Vilar S, Andrews N, Bollaerts K. De Smedt T, et al. Among authors: bollaerts k. PLoS One. 2018 Jun 15;13(6):e0199180. doi: 10.1371/journal.pone.0199180. eCollection 2018. PLoS One. 2018. PMID: 29906276 Free PMC article.

10

Methodology for computing the burden of disease of adverse events following immunization.

McDonald SA, Nijsten D, Bollaerts K, Bauwens J, Praet N, van der Sande M, Bauchau V, de Smedt T, Sturkenboom M, Hahné S. McDonald SA, et al. Among authors: bollaerts k. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):724-730. doi: 10.1002/pds.4419. Epub 2018 Mar 24. Pharmacoepidemiol Drug Saf. 2018. PMID: 29575242 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page